Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $4.87 billion. The enterprise value is $4.98 billion.
| Market Cap | 4.87B |
| Enterprise Value | 4.98B |
Important Dates
The last earnings date was Tuesday, October 21, 2025, before market open.
| Earnings Date | Oct 21, 2025 |
| Ex-Dividend Date | Dec 26, 2024 |
Share Statistics
Balchem has 32.39 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | 32.39M |
| Shares Outstanding | 32.39M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 91.02% |
| Float | 32.23M |
Valuation Ratios
The trailing PE ratio is 32.94 and the forward PE ratio is 27.72. Balchem's PEG ratio is 3.26.
| PE Ratio | 32.94 |
| Forward PE | 27.72 |
| PS Ratio | 4.81 |
| Forward PS | 4.45 |
| PB Ratio | 3.75 |
| P/TBV Ratio | 15.53 |
| P/FCF Ratio | 30.16 |
| P/OCF Ratio | 24.18 |
| PEG Ratio | 3.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.95, with an EV/FCF ratio of 30.82.
| EV / Earnings | 33.38 |
| EV / Sales | 4.91 |
| EV / EBITDA | 19.95 |
| EV / EBIT | 24.29 |
| EV / FCF | 30.82 |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.72 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | 1.06 |
| Interest Coverage | 18.41 |
Financial Efficiency
Return on equity (ROE) is 12.06% and return on invested capital (ROIC) is 8.86%.
| Return on Equity (ROE) | 12.06% |
| Return on Assets (ROA) | 7.87% |
| Return on Invested Capital (ROIC) | 8.86% |
| Return on Capital Employed (ROCE) | 13.36% |
| Revenue Per Employee | $744,708 |
| Profits Per Employee | $109,627 |
| Employee Count | 1,361 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 5.18 |
Taxes
In the past 12 months, Balchem has paid $44.28 million in taxes.
| Income Tax | 44.28M |
| Effective Tax Rate | 22.88% |
Stock Price Statistics
The stock price has decreased by -16.22% in the last 52 weeks. The beta is 0.99, so Balchem's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -16.22% |
| 50-Day Moving Average | 151.50 |
| 200-Day Moving Average | 159.04 |
| Relative Strength Index (RSI) | 39.50 |
| Average Volume (20 Days) | 159,686 |
Short Selling Information
The latest short interest is 459,067, so 1.42% of the outstanding shares have been sold short.
| Short Interest | 459,067 |
| Short Previous Month | 455,881 |
| Short % of Shares Out | 1.42% |
| Short % of Float | 1.42% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
In the last 12 months, Balchem had revenue of $1.01 billion and earned $149.20 million in profits. Earnings per share was $4.57.
| Revenue | 1.01B |
| Gross Profit | 363.07M |
| Operating Income | 205.08M |
| Pretax Income | 193.48M |
| Net Income | 149.20M |
| EBITDA | 249.66M |
| EBIT | 205.08M |
| Earnings Per Share (EPS) | $4.57 |
Balance Sheet
The company has $65.09 million in cash and $172.00 million in debt, giving a net cash position of -$106.91 million or -$3.30 per share.
| Cash & Cash Equivalents | 65.09M |
| Total Debt | 172.00M |
| Net Cash | -106.91M |
| Net Cash Per Share | -$3.30 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 40.09 |
| Working Capital | 217.35M |
Cash Flow
In the last 12 months, operating cash flow was $201.60 million and capital expenditures -$40.00 million, giving a free cash flow of $161.60 million.
| Operating Cash Flow | 201.60M |
| Capital Expenditures | -40.00M |
| Free Cash Flow | 161.60M |
| FCF Per Share | $4.99 |
Margins
Gross margin is 35.82%, with operating and profit margins of 20.23% and 14.72%.
| Gross Margin | 35.82% |
| Operating Margin | 20.23% |
| Pretax Margin | 19.09% |
| Profit Margin | 14.72% |
| EBITDA Margin | 24.63% |
| EBIT Margin | 20.23% |
| FCF Margin | 15.94% |
Dividends & Yields
This stock pays an annual dividend of $0.87, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | $0.87 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | 10.13% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 19.04% |
| Buyback Yield | -0.30% |
| Shareholder Yield | 0.28% |
| Earnings Yield | 3.06% |
| FCF Yield | 3.32% |
Analyst Forecast
The average price target for Balchem is $176.00, which is 16.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $176.00 |
| Price Target Difference | 16.98% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 10.94 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.94 |
| Piotroski F-Score | 7 |